The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study)Cihan Altın, Mehdi Zoghi, Lütfi Bekar et al.|Unknown|2022Cited by 3
Younger heart failure population with higher in-hospital mortalityÜmit Yaşar Si̇nan, Mehdi Zoghi, Ahmet Ekmekçi et al.|Hitit University Institutional Repository|2017Cited by 0